The biomarkers IL6, IL8 and PCT appear promising, and should certainly be subject to new primary studies investigating more thoroughly the prediction of significant infectious morbidity, which includes both clearly defined infections and the sepsis syndrome, across a variety of clinical settings. This evidence concerns the gene CXCL8 and infection.